mation and impaired mitochondrial oxidative phosphorylation are considered key players in the development of several metabolic disorders, including diabetes. We have previously shown inflammation and mitochondrial dysfunction in the hypothalamus of an animal model for anorexia, the anx/anx mouse. Moreover, increased incidence of eating disorders, e.g., anorexia nervosa, has been observed in diabetic individuals. In the present investigation we evaluated whether impaired mitochondrial phosphorylation and inflammation also occur in endocrine pancreas of anorectic mice, and if glucose homeostasis is disturbed. We show that anx/anx mice exhibit marked glucose intolerance associated with reduced insulin release following an intraperitoneal injection of glucose. In contrast, insulin release from isolated anx/anx islets is increased after stimulation with glucose or KCl. In isolated anx/anx islets there is a strong downregulation of the mitochondrial complex I (CI) assembly factor, NADH dehydrogenase (ubiquinone) 1␣ subcomplex, assembly factor 1 (Ndufaf1), and a reduced CI activity. In addition, we show elevated concentrations of free fatty acids (FFAs) in anx/anx serum and increased macrophage infiltration (indicative of inflammation) in anx/anx islets. However, isolated islets from anx/anx mice cultured in the absence of FFAs do not exhibit increased inflammation. We conclude that the phenotype of the endocrine pancreas of the anx/anx mouse is characterized by increased levels of circulating FFAs, as well as inflammation, which can inhibit insulin secretion in vivo. The anx/anx mouse may represent a useful tool for studying molecular mechanisms underlying the association between diabetes and eating disorders.
The anorectic anx/anx mouse arose by a spontaneous mutation in 1976. These mice develop self-starvation and emaciation and die at about 3 wk of age (32) . They eat approximately half as much as the normal littermates (32) . Thus the anx/anx mouse is an attractive model for studying regulation of feeding behavior, in particular anorexia, due to the development of core features associated with human conditions such as anorexia nervosa (AN) (24) and failure to thrive (23) . The anx/anx mouse exhibits several alterations in hypothalamic neurotransmitter/peptide circuits involved in regulation of food intake (4 -6, 12, 20, 37, 38) . Moreover, the anx mutation is linked to downregulation of the NADH dehydrogenase (ubiquinone) 1␣ subcomplex, assembly factor 1 (Ndufaf1), involved in the assembly of complex I (CI) in the mitochondrial oxidative phosphorylation system (OXPHOS), resulting in dysfunctional CI and increased oxidative stress (29) . In addition, studies have demonstrated inflammation in the hypothalamus of the anx/anx mouse (26, 35, 37) . Taken together, these observations provide an explanation for the hypothalamic dysfunction and neurodegeneration found in anx mutant mice (38) .
Mitochondrial oxidative phosphorylation is essential for insulin secretion (16) , and impairment in OXPHOS has been linked to islet inflammation and ␤-cell dysfunction leading to diabetes (22, 30, 31, 42) . Interestingly, a similar CI dysfunction as in the anx/anx mouse has been shown in leukocytes from patients with AN (50) , and an increased incidence of eating disorders has been reported in young women with diabetes (17, 41) . Another observation common for diabetes and AN is increased levels of circulating free fatty acids (FFAs) (7, 14, 19, 40) , which are involved in generation of inflammation (8, 9) .
In the present study we address the question whether OX-PHOS dysfunction and inflammation, previously observed in the hypothalamus of the anx/anx mouse, also occur in the pancreatic islets of these mice. We also examine if there is a disturbance in glucose homeostasis. To that end we studied whole body glucose homeostasis and pancreatic islet function in the anx/anx mouse, monitoring insulin secretion, free cytosolic Ca 2ϩ concentration ([Ca 2ϩ ] i ) handling, mitochondrial function, pancreatic hormone levels, serum levels of FFAs, and expression of inflammatory markers.
METHODS

Animals.
All experiments including animals were conducted in accordance with the European Union directive 2010/63/EU and have been approved by the ethical committee, Stockholms norra djurförsöksetiska nämnd. Heterozygous anx breeding pairs (B6C3Fe-a/a-anx A/ϩ a) (the Jackson Laboratory, Bar Harbor, ME) were used to set up an intercross. Genotyping was performed using simple sequence length polymorphism markers (29, 32) . By postnatal day [20] [21] , when the experiments were performed, the average weight of the anx/anx mouse is ϳ5 g compared with ϳ8 g for the wild-type (wt) mouse. For some mice (anx/anx n ϭ 6; wt n ϭ 11) pancreas was weighed after dissections. For all experiments, except perfusion with formalin fixative, unanesthetized mice were used. All experimental groups contained mice of both genders.
Intraperitoneal glucose tolerance test. An intraperitoneal glucose tolerance test (ipGTT) was performed after 5 h fasting (anx/anx n ϭ 8; wt n ϭ 11), or in the fed state (anx/anx n ϭ 13; wt n ϭ 15). A blood sample was taken from the tail tip (time ϭ 0 min, basal state), after which the mice received a glucose injection (2 mg glucose/g body wt ip). Additional samples were collected at 30, 60, and 90 min postinjection. The glucose levels were measured throughout the test, using an Accu-Chek blood glucose analyzer (Roche Diagnostics, Indianapolis, IN). For some animals (n ϭ 5/genotype) blood samples were also used for measurement of insulin levels at the same time points. Serum was prepared and analyzed using the Ultrasensitive Mouse Insulin ELISA kit (Mercodia, Uppsala, Sweden) and a spectrophotometer (Multiscan EX; Thermo Fischer Scientific, Waltham, MA). Glucose (G AUC) and insulin (IAUC) areas under the curve were calculated using Image J Software (National Institutes of Health, Bethesda, MD). Analysis was also done after normalizing to the basal state values.
Pancreatic islet isolation. Islets were isolated from anx/anx and wt mice by the collagenase method (28) . Briefly, the pancreas was inflated with Hank's balanced salt solution (Invitrogen, Carlsbad, CA) containing 1 mg/ml collagenase A (Sigma-Aldrich, St. Louis, MO) and kept at 37°C for 15 min. After digestion, islets were collected manually under a stereomicroscope and cultured overnight in RPMI-1640 culture medium (Invitrogen) containing 11 mM glucose supplemented with 2 mM L-glutamine, 100 U/ml penicillin (Roche Diagnostics), 0.1 mg/ml streptomycin, and 10% fetal calf serum.
Pancreatic islet size distribution. The size of isolated islets from anx/anx and wt mice was measured on micrographs using 40 -100 islets/animal.
Pancreatic insulin, glucagon, and somatostatin content. Pancreatic hormones were extracted from whole pancreas (n ϭ 7/genotype) with 14 ml acid ethanol. The extracts were diluted 1:20 to 1:50 and analyzed by Ultrasensitive Mouse Insulin ELISA (Mercodia) or Glucagon ELISA (Mercodia). For normalization total protein content was Islet insulin content. For measurement of insulin content, islets from anx/anx (n ϭ 10) and wt (n ϭ 9) mice were used. The islets were incubated with M-PER (Pierce/Thermo Scientific, Waltham, MA) for 15 min, followed by centrifugation at 20,000 g for 10 min. The supernatant was used for analysis of insulin content with the ArcDia TPX assay (Arc-Dia Group, Turku, Finland) using a human insulin standard (Sigma-Aldrich). For total protein content, islets were homogenized in RIPA buffer containing 25 mM Tris HCl (pH 7.6), 150 mM NaCl, 1% Nonidet P-40, 1% sodium deoxycholate, 0.1% SDS, and 1ϫ protease inhibitor cocktail (Roche Diagnostics). For normalization total protein content was measured in the extracts with the BCA Protein Assay kit (Thermo Scientific).
Measurements of static insulin release. For measurements of static insulin release from isolated islets, groups of three islets from anx/anx (n ϭ 4) and wt (n ϭ 3) mice were preincubated in Krebs-Ringer bicarbonate buffer (KRBB), containing 25 mM HEPES (pH 7.4), 125 mM NaCl, 5.9 mM KCl, 1.28 mM CaCl 2, 1.2 mM MgCl2, 0.1% BSA, and 3 mM glucose, 30 min at 37°C. This was followed by incubation in KRBB containing 3 mM glucose, and then in the same buffer containing 11 mM glucose, and finally containing 25 mM KCl, each incubation 30 min, at 37°C. Media were stored at Ϫ20°C until analyzed using an Ultrasensitive Mouse Insulin ELISA kit (Mercodia), as described above. The values were normalized by the number of islets.
Measurement of dynamic insulin release. For measurements of dynamic insulin release, 30 islets from 6 animals/genotype were preincubated in KRBB containing 3 mM glucose for 30 min at 37°C. The islets were immobilized in Bio-Gel P-4 polyacrylamide beads (Bio-Rad, Hercules, CA) and continuously perifused at a flow rate of 75 l/min at 37°C. The stimuli consisted of 3 mM glucose followed by 11 mM glucose, 3 mM glucose, and, finally, 25 mM KCl. Samples of perifusate were collected every 2 min, starting 10 min after onset of perifusion. Samples were stored at Ϫ20°C until analyzed with the ArcDia TPX assay (Arc-Dia Group).
Measurement of [Ca 2ϩ ]i. Measurements of changes in [Ca 2ϩ ]i during stimulation with high glucose (11 mM) or KCl (25 mM) were performed as described (53) . Islets from anx/anx (n ϭ 8) and wt (n ϭ 7) mice were transferred to KRBB containing 3 mM glucose and 2 M fura 2-AM (Invitrogen) and incubated 50 min at 37°C. Single islets were transferred to an open perifusion chamber and fixed to the cover slip with PuraMatrix Peptide Hydrogel (BD Biosciences, Franklin Lakes, NJ). The chamber was mounted on a Zeiss Axiovert 35 M microscope with a Zeiss Fluar ϫ40/1.30 objective (Carl Zeiss, Göt-tingen, Germany) connected to a Spex Fluorolog spectrophotometer. Changes in [Ca 2ϩ ]i were measured as the 340-to-380 nm fluorescence ratio. Islets were stimulated with 11 mM glucose and 25 mM KCl in KRBB maintained at 37°C.
CI in-gel activity assay. For in-gel activity assay, crude mitochondria from anx/anx and wt islets were isolated as described (27) . Extracts were prepared using a NativePAGE Sample Prep Kit with 0.5% N-dodecyl-␤-D-maltoside as a detergent (Invitrogen), and protein concentration was determined as described above. NativePAGE gradient gels, 3-12% (Invitrogen), were loaded with 5 g of mitochondrial protein/lane. Proteins from a maximum of three mice per genotype were pooled together. After electrophoresis, gels were further processed for CI in-gel activity using a solution containing 3 mM Tris·HCl, pH 7.4, 0.1 mg/ml NADH (Sigma-Aldrich), and 0.5 mg/ml nitroblue tetrazolium (Sigma-Aldrich), 20 min at 37°C.
Mitochondrial membrane potential of pancreatic islets. Isolated islets from anx/anx (n ϭ 3) and wt (n ϭ 4) mice were incubated in 3 mM glucose KRBB supplemented with 32 M Rh-123 for 10 min. The increased mitochondrial membrane potential (MMP), in response to shifting from 3 to 11 mM glucose, was recorded as described (25) , using the same system as for the Ca 2ϩ measurements with 500 nm excitation and 515/565 nm emission. Free fatty acids in serum. The concentration of FFAs was analyzed in serum from nonfasted anx/anx (n ϭ 8) and wt (n ϭ 6) mice using the Free Fatty Acid Quantification kit (Sigma-Aldrich). In brief, samples were incubated with acyl-CoA synthase reagent for 30 min at 37°C followed by enzyme mix and enhancer. The resulting fluorescent signal was recorded with a plate reader ( ex ϭ 535/em ϭ 587 nm).
Immunohistochemical analysis of pancreatic islets. Mice used for immunohistochemical analysis of pancreatic islets were anesthetized using isoflurane (Forene; Abbot Scandinavia, Solna, Sweden), perfused with formalin fixative, and processed as described (37) . For the Ki-67 antiserum, antigen retrieval with sodium citrate buffer was employed. Sections were incubated with antiserum against Iba1 (1: 4,000; Wako Pure Chemical Industries, Osaka, Japan), F4/80 (1: 4,000; Serotec, Kidlington, UK), glucagon (1:20,000) (54), somatostatin (1:50,000) (3), or Ki-67 (1:2,000; AbCam, Cambridge, UK) overnight at 4°C. This was followed by incubation with horseradish peroxidase-conjugated secondary antibody (1:200; Dako, Copenhagen, Denmark) and then processed according to the tyramide signal amplification (TSA)-plus Fluorescein System (PerkinElmer Life Science, Boston, MA) (1). For double labeling, the TSA technique was followed by conventional immunohistochemistry with antibodies against insulin (Bio-Yeda, Rehovot, Israel) or Iba1, and subsequently by secondary antibodies conjugated with Cy3 or rhodamine red (1:80; Jackson ImmunoResearch, West Grove, PA) for 30 min, at 37°C. Finally sections were counterstained with DAPI.
Immunohistochemical analysis of cultured islets. The isolation of islets was performed as described above. After overnight culturing, islets were fixed for 20 min in the same ice-cold fixative as for the perfusion (see above), followed by rinsing in phosphate-buffered saline embedding and freezing on dry ice. The islets were cut, thaw-mounted on glass slides, and immunohistochemically labeled with antiserum to Iba1, insulin, or F4/80 as described above for the pancreas sections.
Microscopy and quantification of the immunohistochemistry. After immunohistochemical processing, sections were analyzed with a Nikon Eclipse E600 Fluorescence microscope and LSM 510 Meta Confocal Microscopy (Carl Zeiss).
For intact pancreas, Iba1-immunopostive, star-shaped cells (indicative of activated state) were counted, either within, or within plus the immediate surrounding of the islet (as shown in Fig. 5B ). The evaluation was always performed in medium-sized islets (ϳ50 -100 m, n ϭ 2-5 islets/animal) from anx/anx (n ϭ 4) and wt (n ϭ 5) mice. In addition, the density of Iba1-positive labeling with intensity above a set threshold was calculated "within plus surrounding" the islet by the Image J Software (National Institutes of Health) in anx/anx (n ϭ 3) and wt (n ϭ 4) pancreas. Iba1-positive, star-shaped cells were also counted in two to five isolated islets from anx/anx (n ϭ 3) and wt (n ϭ 4) mice.
To estimate the proportion of the islets that are covered by insulin, glucagon, or somatostatin immunoreactivity (ir) the borders of medium-size islets (n ϭ 4 -11) from anx/anx and wt (n ϭ 3-6/genotype) intact pancreas were outlined using DAPI, and the area fraction of the islet covered by respective immunoreactivity above a set threshold was subsequently calculated by Image J.
Ki-67-immunoreactive cells were counted in medium-size islets (n ϭ 4 -12) from four intact pancreas per genotype.
Statistical analyses. For all statistical analyses, ANOVA or unpaired t-test was used, with the exception of analysis of the islet size distribution, where the Chi square test was used. Values are presented as mean values Ϯ SE, and statistical significance was set to P Ͻ 0.05. 
RESULTS
Blood glucose and serum insulin concentrations after GTT in anx/anx mice. Blood glucose concentrations of anx/anx mice, fasted for 5 h before ipGTT, were significantly lower compared with wt (Fig. 1A) . However, by 30 min postintraperitoneal glucose injection, blood glucose was markedly elevated in anx/anx mice, before returning to wt values at 60 and 90 min. Also, the normalized blood glucose levels (Fig. 1B) and G AUC were significantly increased in anx/anx mice, indicating glucose intolerance (Fig. 1E) . This was associated with a markedly depressed islet insulin secretion in response to the ipGTT in anx/anx mice, as evident from serum insulin values, and by the I AUC (Fig. 1, C, D, and F) . Nonfasted anx/anx mice revealed significantly lower blood glucose concentrations in anx/anx vs. wt mice, but, again, an exaggerated blood glucose increase was seen after intraperitoneal injection of glucose (Fig. 1G) .
anx/anx pancreas weight and islet size distribution. The anx/anx pancreas weighed significantly less than the wt pancreas (Fig. 2B) . However, the difference correlates with the difference in body weight between anx/anx and wt mice, as seen after normalization with body weight (Fig. 2C) . The size distribution of islets did not differ significantly between groups (Fig. 2D) .
anx/anx pancreatic hormones. ELISA revealed no significant difference between anx/anx and wt in total pancreatic insulin content or glucagon content after normalization with total pancreatic protein content (Figs. 2E and 3D) . Furthermore, the percentage of islet area occupied by insulin immunoreactivity, i.e., ␤-cells, did not differ between groups ( Fig.  2A) . Similarly, no significant differences were obtained for the percentage occupancy by glucagon or somatostatin (Fig. 3,  A-C and E-G) ; however, a trend (P ϭ 0.14) toward more somatostatin immunoreactivity was seen in anx/anx (Fig. 3G) .
In vitro insulin secretion from anx/anx islets. To examine the cause for the reduced insulin secretion after the ipGTT, experiments were performed on isolated islets. Significantly less insulin was seen in anx/anx islets after normalizing with protein content (Fig. 4A) . Next, we evaluated dynamic and static insulin secretion in response to glucose stimulation in isolated islets. Pancreatic islets from anx/anx and wt mice were studied in the presence of 3 or 11 mM glucose. Insulin concentration at 3 mM (basal) glucose concentration was similar between groups, but, after addition of 11 mM glucose, anx/anx islets showed significantly higher insulin release compared with wt islets (Figs. 3G and 4 , B and C). Additionally, we depolarized islets with 25 mM KCl, which also resulted in increased insulin release from anx/anx islets (Fig. 4, B and C) . Thus, insulin secretion from cultured islets isolated from anx/ anx mice were increased compared with wt values, even though isolated and cultured islets have a lower insulin content. This indicates that the reduced insulin secretion in response to the ipGTT in the anx/anx mice is not due to a decreased capacity to secrete insulin. Fig. 5, A and B) , whereas wt islets showed a normal first initial decrease in [Ca 2ϩ ] i in all traces (representative images in Fig. 3, C and D) . This decrease in [Ca 2ϩ ] i due to uptake of Ca 2ϩ in the endoplasmic reticulum is seen under normal circumstances (15) . After stimulation with high glucose, the increase in [Ca 2ϩ ] i was significantly lower in anx/anx compared with wt islets (Fig. 5, A-E) . Furthermore, changing glucose concentration from 11 to 3 mM was accompanied by a slower return of [Ca 2ϩ ] i to basal levels in anx/anx than seen in wt islets (Fig.  5, A-D) . However, in the presence of KCl the increase in Mitochondrial dysfunction of anx/anx islets. MMP 3G/11G of anx/anx islets was decreased by ϳ50% compared with wt islets (Fig. 5F) . Furthermore, the in-gel activity assay showed a fainter band in anx/anx islets indicative of reduced CI activity in anx/anx vs. wt islets (Fig. 5G) .
Free fatty acids in anx/anx serum. Quantification of FFAs revealed a 50% increase in serum from nonfasted anx/anx mice (0.30 Ϯ 0.04 vs. 0.20 Ϯ 0.01 nmol/l in wt; P Ͻ 0.05).
Signs of inflammation in anx/anx islets. Immunohistochemical analysis of intact pancreas with Iba1 antiserum as markers for cells in the monocytic lineage, e.g., microglia and macrophages (18) , revealed significantly increased number of labeled, star-shaped cells both within islets, and "within plus surrounding islets" when comparing intact anx/anx and wt pancreas (Fig. 6, A-C) . Also the density of Iba1-positive cells "within plus surrounding the islet" was significantly increased in anx/anx pancreas vs. wt (quantified by Image J) (Fig. 6D) . In contrast, when islets were isolated and cultured overnight, there was no difference in the number of Iba1-positive cells between anx/anx and wt mice (Fig. 6, E-G) . This indicates increased macrophage infiltration of the anx/anx pancreatic islets. applies to A, B, H, and I) and 20 m (F) (applies to E, F, and  J) . Values are means Ϯ SE. **P Ͻ 0.01.
To further establish specificity, double-labeling experiments with Iba1 and F4/80 antiserum, the latter another marker for macrophages, were carried out. These results showed an almost complete overlap between the two markers in all experimental groups (Fig. 6, H-J) .
␤-Cell proliferation in anx/anx islets. Immunohistochemical labeling with Ki-67 as a marker for proliferation revealed an equal number of Ki-67-immunoreactive ␤-cells in anx/anx and wt pancreatic islets (Fig. 7, A-C) .
DISCUSSION
In the present study we document an association between anorexia, glucose intolerance, and pancreatic ␤-cell dysfunction. We show that the anorexia of the anx/anx mice is associated with glucose intolerance following an ipGTT, and disturbed pancreatic islet insulin secretion that, however, cannot be explained by changes in ␤-cell mass, total pancreatic insulin content, or ␤-cell proliferation. Also, the total pancreatic glucagon levels are not changed in anx/anx compared with wt mice, neither are there any significant differences in the area fraction of the islet covered by glucagon or somatostatin immunoreactivity. Furthermore, isolated and overnight-cultured anx/anx islets have reduced insulin content but are able to release more insulin upon stimulation compared with wt islets. The most straightforward explanation for the attenuated insulin secretion in vivo is the elevated level of circulating FFA in anx/anx mice, which is discussed in more detail below.
Impaired [Ca 2ϩ ] i handling and exaggerated insulin secretion in isolated anx/anx islets. Changes in [Ca 2ϩ ] i play an important role in the mechanism underlying insulin secretion, and we therefore evaluated this process in isolated anx/anx islets (16) . The [Ca 2ϩ ] i response to a stimulatory glucose concentration was attenuated in isolated anx/anx islets, whereas the response to KCl was similar in both types of islets. At the same time, the in vitro insulin release was increased from anx/anx islets in response to both high glucose and KCl. A key event of glucose-induced increase in [Ca 2ϩ ] i in the ␤-cell is metabolism of the sugar, leading to an increase in the ATP-to-ADP ratio with subsequent closure of ATP-sensitive potassium channels. The closure leads to depolarization and opening of voltage-gated Ca 2ϩ channels, resulting in Ca 2ϩ influx and subsequently insulin secretion (16 (16) . Previously we showed a marked downregulation of the CI assembly factor Ndufaf1 in anx/anx pancreas (29) . Therefore, we evaluated mitochondrial function of anx/anx islets and found a decreased CI activity and an impaired change in MMP, shifting glucose concentration from 3 to 11 mM. Thus ] i is elevated to the level needed to trigger insulin secretion, the release process is dependent on the efficacy of the exocytotic machinery in the ␤-cell, that is, on the proteins involved in vesicle release, e.g., the so-called soluble N-ethylmaleimide-sensitive factor-activating protein receptor (SNARE) proteins (43, 44) . In fact, vesicle-associated membrane protein 3 (cellubrevin) and synaptotagmin I, two SNAREs, are upregulated in the anx/anx hypothalamus (29) . Both of these proteins are also expressed by ␤-cells (36, 48) . We hypothesize that such genes are also upregulated in anx/anx islets and contribute to the increased insulin secretion in vitro, while some other mechanism(s) seems to be involved in the decreased secretion in vivo.
Elevated serum FFA and islet inflammation in the anx/anx mouse. Chronically elevated concentrations of FFAs have been shown to inhibit glucose-induced insulin secretion and to lead to pancreatic inflammation and ␤-cell dysfunction (10, 51). Here we found elevated serum FFA concentrations in anx/anx serum and, in parallel, an increased number of Iba1-and F4/80-positive cells in anx/anx islets, indicating macrophage infiltration and inflammation (18, 21) . Interestingly, increased levels of circulating FFAs are also seen in obesity and diabetes and in AN (8, 9, 40) due to high levels of fat deposits in the former and an excessive breakdown of these deposits in the latter (7, 14, 19, 40) . High FFA concentrations in serum could thus be the common denominator for the islet dysfunction and inflammation now documented in both diabetic and anorectic conditions. Thus, the increased systemic FFAs in the anx/anx mouse may account for the discrepancy between the in vivo and in vitro results on insulin secretion. When isolated anx/anx islets were cultured in medium devoid of FFAs, insulin secretion was no longer reduced, which can be explained by two mechanisms. One is a direct lipotoxic effect of FFA on the pancreatic ␤-cell possibly involving mitochondrial dysfunction (13, 45) and leading to decreased glucose-induced insulin secretion (39, 55) . Another mechanism involves FFA-induced inflammation (10, 44) . Indeed, in sections from intact pancreas, the number of macrophages was much lower in wt than anx/anx islets, the majority seen in the area immediately surrounding the anx/anx islet. In contrast, we detected no difference in the number of macrophages infiltrating isolated cultured islets. The majority of macrophages seen in sections from intact pancreas were found in the area immediately surrounding the anx/anx islets; the number of macrophages was much lower in wt islets. Macrophages release proinflammatory cytokines, e.g., interleukin-1␤, which inhibits insulin secretion (11, 33) . Thus it is likely that the disturbed insulin secretion documented here in an anorectic mouse model is related to FFA-induced pancreatic islet dysfunction and inflammation. In addition, the CI deficiency and impairment in mitochondrial function observed in anx/anx mouse can also lead to pancreatic inflammation and dysfunction. This is supported by a recent study by Yu et al. (52) , showing that mitochondrial CI deficiency triggers inflammation in retinal ganglion cells.
In conclusion, the phenotype of the endocrine pancreas of the anorectic anx/anx mouse is seriously compromised, likely as a result of increased serum concentrations of FFA leading to pancreatic islet inflammation and dysfunction. This may be of clinical relevance, since an increased incidence of eating disorders has been reported in young women with diabetes (17, 34) . We conclude that several of the phenotypes documented in the anx/anx mouse, including self-starvation, emaciation, mitochondrial dysfunction, and increased levels of FFA, are shared with AN patients, thus illustrating the value of these mice for studies exploring the mechanisms involved in the AN pathology.
